XML 20 R11.htm IDEA: XBRL DOCUMENT
v3.22.2

Share-Based Compensation | 6 Months Ended
--- | ---
Jun. 30, 2022
Share-based Payment Arrangement [Abstract] |
Share-Based Compensation | Share-Based Compensation The Corporation adopted the 2019 Equity Incentive Plan (the “Plan”) during the quarter ended June 30, 2019. The Plan is administered by the Compensation Committee of the Board of Directors (the “Board”) of the Corporation and provides for the grant of equity ownership opportunities through incentive stock options and nonqualified stock options (“Stock Options”), restricted stock, restricted stock units, dividend equivalent units, and any other type of award permitted by the Plan. As of June 30, 2022, 154,002 shares were available for future grants under the Plan. Shares covered by awards that expire, terminate, or lapse will again be available for the grant of awards under the Plan. Restricted Stock Under the Plan, the Corporation may grant restricted stock awards (“RSA”), restricted stock units (“RSU”), and other stock-based awards to plan participants, subject to forfeiture upon the occurrence of certain events until the dates specified in the participant’s award agreement. While restricted stock is subject to forfeiture, restricted stock award participants may exercise full voting rights and will receive all dividends and other distributions paid with respect to the restricted shares. Restricted stock units do not have voting rights and are provided dividend equivalents. The restricted stock granted under the Plan is typically subject to a vesting period. Compensation expense for restricted stock is recognized over the requisite service period of generally three or four years for the entire award on a straight-line basis. Upon vesting of restricted stock, the benefit of tax deductions in excess of recognized compensation expense is reflected as an income tax benefit in the unaudited Consolidated Statements of Income. The Corporation may issue a combination of performance-based restricted stock units (“PRSU”) and time-based restricted stock awards to its plan participants. Vesting of the performance-based restricted stock units will be measured on the relative Total Shareholder Return (“TSR”) and relative Return on Equity (“ROE”) and will cliff-vest after a three-year measurement period based on the Corporation’s TSR performance and ROE performance compared to a broad peer group of over 100 banks. At the end of the performance period, the number of actual shares to be awarded varies between 0% and 200% of target amounts. The restricted stock awards issued to executive officers will vest ratably over a three-year period. Compensation expense is recognized for PRSU over the requisite service and performance period of generally three years for the entire expected award on a straight-line basis. The compensation expense for the awards expected to vest for the percentage of performance-based restricted stock units subject to the ROE metric will be adjusted if there is a change in the expectation of ROE. The compensation expense for the awards expected to vest for the percentage of performance based restricted stock units subject to the TSR metric are never adjusted, and are amortized utilizing the accounting fair value provided using a Monte Carlo pricing model. Restricted stock activity for the year ended December 31, 2021 and the six months ended June 30, 2022 was as follows:
|  | RSA |  | Weighted Average Grant Price |  | PRSU |  | Weighted Average Grant Price |  | RSU |  | Weighted Average Grant Price |  | Total |  | Weighted Average Grant Price
Nonvested balance as of January 1, 2021 |  | 143,246 |  |  | $ | 23.04 |  |  | 39,570 |  |  | $ | 28.85 |  |  | 4,988 |  |  | $ | 24.08 |  |  | 187,804 |  |  | $ | 24.29 |
Granted (1) |  | 67,515 |  |  | 22.39 |  |  | 23,550 |  |  | 27.12 |  |  | 2,065 |  |  | 21.68 |  |  | 93,130 |  |  | 23.57 |
Vested |  | (61,384) |  |  | 22.26 |  |  | — |  |  | — |  |  | (2,001) |  |  | 22.91 |  |  | (63,385) |  |  | 22.28 |
Forfeited |  | (7,760) |  |  | 23.24 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (7,760) |  |  | 23.24 |
Nonvested balance as of December 31, 2021 |  | 141,617 |  |  | 23.06 |  |  | 63,120 |  |  | 28.20 |  |  | 5,052 |  |  | 23.56 |  |  | 209,789 |  |  | 24.62 |
Granted (1) |  | 55,275 |  |  | 33.59 |  |  | 37,335 |  |  | 24.71 |  |  | 335 |  |  | 33.60 |  |  | 92,945 |  |  | 30.02 |
Vested |  | (46,367) |  |  | 23.38 |  |  | (43,020) |  |  | 18.91 |  |  | (1,552) |  |  | 24.17 |  |  | (90,939) |  |  | 21.28 |
Forfeited |  | (1,807) |  |  | 25.60 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1,807) |  |  | 25.60 |
Nonvested balance as of June 30, 2022 |  | 148,718 |  |  | $ | 26.84 |  |  | 57,435 |  |  | $ | 32.89 |  |  | 3,835 |  |  | $ | 24.19 |  |  | 209,988 |  |  | $ | 28.45 |
Unrecognized compensation cost (in thousands) |  | $ | 3,222 |  |  |  |  | $ | 1,239 |  |  |  |  | $ | 70 |  |  |  |  | $ | 4,531 |  |  |
Weighted average remaining recognition period (in years) |  | 2.67 |  |  |  | 2.00 |  |  |  | 1.97 |  |  |  | 2.47 |  |
(1)The number of restricted shares/units shown includes the shares that would be granted if the target level of performance is achieved plus related to the performance based restricted stock units. The number of shares actually issued may vary. During the six months ended June 30, 2022, an additional 21,510 were issued related to actual performance results of previously granted awards. Employee Stock Purchase Plan During 2020, an employee stock purchase plan ("ESPP") was approved by the Corporation’s shareholders and is offered to all qualifying employees. The Corporation is authorized to issue up to 250,000 shares of common stock under the ESPP. The plan qualifies as an employee stock purchase plan under section 423 of the Internal Revenue Code of 1986. Under the ESPP, eligible employees may enroll in a three month offer period that begins January, April, July, and October of each year. Employees may elect to purchase a limited number of shares on the Corporation's common stock at 90% of the fair market value on the last day of the offering period. The ESPP is treated as a compensatory item for purposes of share-based compensation expense. During the six months ended June 30, 2022, the Corporation issued 2,634 shares of common stock under the ESPP. As of June 30, 2022, 238,122 shares remained available for issuance under the ESPP. Share-based compensation expense related to restricted stock and ESPP included in the unaudited Consolidated Statements of Income was as follows:
|  | For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
|  | 2022 |  | 2021 |  | 2022 |  | 2021
|  | (In Thousands) |  |
Share-based compensation expense |  | $ | 645 |  |  | $ | 607 |  |  | $ | 1,254 |  |  | $ | 1,138 |

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration